- Home
- KMDA vs KRNY Comparison
KMDA vs KRNY Comparison
Compare KMDA & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- KRNY
- Stock Information
- Founded
- KMDA 1990
- KRNY 1884
- Country
- KMDA Israel
- KRNY United States
- Employees
- KMDA N/A
- KRNY N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- KRNY Savings Institutions
- Sector
- KMDA Health Care
- KRNY Finance
- Exchange
- KMDA Nasdaq
- KRNY Nasdaq
- Market Cap
- KMDA 399.7M
- KRNY 399.1M
- IPO Year
- KMDA N/A
- KRNY 2005
- Fundamental
- Price
- KMDA $7.77
- KRNY $6.96
- Analyst Decision
- KMDA Strong Buy
- KRNY Buy
- Analyst Count
- KMDA 3
- KRNY 2
- Target Price
- KMDA $14.67
- KRNY $7.75
- AVG Volume (30 Days)
- KMDA 83.7K
- KRNY 365.2K
- Earning Date
- KMDA 08-13-2025
- KRNY 07-24-2025
- Dividend Yield
- KMDA 2.56%
- KRNY 6.47%
- EPS Growth
- KMDA 31.21
- KRNY N/A
- EPS
- KMDA 0.28
- KRNY N/A
- Revenue
- KMDA $167,235,000.00
- KRNY $148,135,000.00
- Revenue This Year
- KMDA $14.51
- KRNY $2.69
- Revenue Next Year
- KMDA $9.31
- KRNY $24.18
- P/E Ratio
- KMDA $27.53
- KRNY N/A
- Revenue Growth
- KMDA 11.83
- KRNY 3.61
- 52 Week Low
- KMDA $4.93
- KRNY $5.45
- 52 Week High
- KMDA $9.16
- KRNY $8.59
- Technical
- Relative Strength Index (RSI)
- KMDA 67.59
- KRNY 72.66
- Support Level
- KMDA $7.61
- KRNY $6.41
- Resistance Level
- KMDA $7.86
- KRNY $6.59
- Average True Range (ATR)
- KMDA 0.20
- KRNY 0.19
- MACD
- KMDA 0.03
- KRNY 0.08
- Stochastic Oscillator
- KMDA 69.98
- KRNY 100.00
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.